Esperion Therapeutics, Inc. (ESPR) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 80.1M | 168.45M | 87.31M | 82.39M | 65M | 69.11M | 51.63M | 73.83M | 137.74M | 32.25M | 33.97M | 25.79M | 24.33M | 18.82M | 18.98M | 18.84M | 18.84M | 15.4M | 14.41M | 40.66M |
| Revenue Growth % | 23.25% | 143.73% | 69.1% | 11.58% | -52.81% | 114.3% | 52% | 186.33% | 466.14% | 71.38% | 78.97% | 36.86% | 29.16% | 22.19% | 31.72% | -53.66% | 136.1% | 59.79% | 275.92% | -80.84% |
| Cost of Goods Sold | 34.57M | 27.85M | 55.42M | 28.54M | 31.54M | 25.63M | 17.29M | 15.61M | 10.07M | 11.45M | 13.38M | 6.79M | 11.65M | 4.16M | 6.51M | 9.18M | 7.13M | 5.08M | 5.56M | 1.8M |
| COGS % of Revenue | 43.16% | 16.54% | 63.48% | 34.65% | 48.52% | 37.09% | 33.48% | 21.14% | 7.31% | 35.51% | 39.38% | 26.32% | 47.89% | 22.11% | 34.28% | 48.7% | 37.83% | 32.95% | 38.57% | 4.43% |
| Gross Profit | 45.53M | 140.59M | 31.89M | 53.84M | 33.46M | 43.48M | 34.35M | 58.23M | 127.66M | 20.8M | 20.59M | 19M | 12.68M | 14.66M | 12.47M | 9.66M | 11.71M | 10.33M | 8.85M | 38.86M |
| Gross Margin % | 56.84% | 83.46% | 36.52% | 65.35% | 51.48% | 62.91% | 66.52% | 78.86% | 92.69% | 64.49% | 60.62% | 73.68% | 52.11% | 77.89% | 65.72% | 51.3% | 62.17% | 67.05% | 61.43% | 95.57% |
| Gross Profit Growth % | 36.09% | 223.33% | -7.15% | -7.53% | -73.79% | 109.07% | 66.79% | 206.45% | 907.02% | 41.89% | 65.08% | 96.59% | 8.25% | 41.95% | 40.93% | -75.13% | 89.07% | 29.89% | 148.76% | -81.66% |
| Operating Expenses | 52.11M | 55.36M | 41.85M | 46.75M | 55.55M | 47.9M | 50.37M | 55.65M | 55.39M | 63.16M | 48.13M | 56.06M | 61.28M | 57.17M | 54.1M | 62.04M | 54.7M | 65.95M | 64.6M | 71.39M |
| OpEx % of Revenue | 65.06% | 32.86% | 47.93% | 56.74% | 85.47% | 69.31% | 97.56% | 75.37% | 40.22% | 195.86% | 141.67% | 217.4% | 251.89% | 303.81% | 285.02% | 329.29% | 290.4% | 428.24% | 448.3% | 175.59% |
| Selling, General & Admin | 43.12M | 41.43M | 41.85M | 39.51M | 43M | 36.92M | 39.98M | 44.19M | 41.99M | 45.42M | 33.24M | 33.96M | 29.9M | 24.14M | 24.95M | 29.61M | 30.38M | 38.34M | 39.27M | 46.32M |
| SG&A % of Revenue | 53.84% | 24.6% | 47.93% | 47.96% | 66.15% | 53.43% | 77.42% | 59.84% | 30.48% | 140.85% | 97.85% | 131.7% | 122.9% | 128.27% | 131.48% | 157.15% | 161.29% | 248.93% | 272.5% | 113.92% |
| Research & Development | 8.99M | 13.93M | 14.13M | 7.24M | 12.56M | 10.98M | 10.4M | 11.46M | 13.4M | 17.74M | 14.88M | 22.1M | 31.38M | 33.03M | 29.14M | 32.43M | 24.32M | 27.62M | 25.33M | 25.07M |
| R&D % of Revenue | 11.22% | 8.27% | 16.18% | 8.79% | 19.32% | 15.88% | 20.14% | 15.52% | 9.73% | 55.01% | 43.82% | 85.7% | 128.99% | 175.54% | 153.55% | 172.14% | 129.11% | 179.31% | 175.8% | 61.67% |
| Other Operating Expenses | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.58M | 85.23M | -9.96M | 7.09M | -22.1M | -4.42M | -16.03M | 2.58M | 72.27M | -42.37M | -27.53M | -37.06M | -48.6M | -42.51M | -41.62M | -52.38M | -42.99M | -55.63M | -55.74M | -32.53M |
| Operating Margin % | -8.22% | 50.6% | -11.41% | 8.61% | -34% | -6.4% | -31.04% | 3.49% | 52.47% | -131.37% | -81.05% | -143.71% | -199.78% | -225.92% | -219.3% | -277.99% | -228.23% | -361.2% | -386.88% | -80.01% |
| Operating Income Growth % | 70.22% | 2028.35% | 37.86% | 175.11% | -130.57% | 89.57% | 41.79% | 106.96% | 248.69% | 0.34% | 33.85% | 29.25% | -13.06% | 23.58% | 25.33% | -60.99% | 48.1% | 41.79% | 30.8% | -125.19% |
| EBITDA | -6.55M | 85.26M | -9.93M | 7.12M | -22.07M | -4.39M | -16M | 2.59M | 72.31M | -42.36M | -27.51M | -37.01M | -48.52M | -42.42M | -41.52M | -52.23M | -42.84M | -55.48M | -55.59M | -32.38M |
| EBITDA Margin % | -8.18% | 50.62% | -11.38% | 8.64% | -33.96% | -6.36% | -30.99% | 3.51% | 52.5% | -131.35% | -80.98% | -143.52% | -199.45% | -225.43% | -218.75% | -277.19% | -227.42% | -360.2% | -385.81% | -79.64% |
| EBITDA Growth % | 70.3% | 2040.79% | 37.92% | 175.09% | -130.52% | 89.63% | 41.83% | 107% | 249.02% | 0.14% | 33.75% | 29.14% | -13.28% | 23.53% | 25.32% | -61.29% | 48.19% | 41.86% | 30.85% | -125.04% |
| D&A (Non-Cash Add-back) | 27K | 26K | 26K | 27K | 26K | 27K | 26K | 10K | 41K | 6K | 26K | 51K | 81K | 92K | 105K | 150K | 153K | 153K | 153K | 153K |
| EBIT | -6.58M | 85.23M | -9.28M | 7.76M | -21.02M | -4.9M | -14.44M | -48.2M | 75.05M | -41.29M | -26.25M | -35.4M | -47.33M | -41.16M | -40.96M | -52.06M | -42.67M | -51.69M | -55.73M | -32.52M |
| Net Interest Income | 19.8M | -21.54M | -22.05M | -20.49M | -19.43M | -16.42M | -15.08M | -13.72M | -14.02M | -15.06M | -14.99M | -14.54M | -14.39M | -14.33M | -14.15M | -14.27M | -14.06M | -13.43M | -13.65M | -11.14M |
| Interest Income | 0 | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -19.8M | 22.64M | 22.05M | 20.49M | 19.43M | 16.42M | 15.08M | 13.72M | 14.02M | 15.06M | 14.99M | 14.54M | 14.39M | 14.33M | 14.15M | 14.27M | 14.06M | 13.43M | 13.65M | 11.14M |
| Other Income/Expense | -18.61M | -21.56M | -21.37M | -19.82M | -18.36M | -16.9M | -13.5M | -64.5M | -11.25M | -13.98M | -13.72M | -12.88M | -13.11M | -12.97M | -13.49M | -13.95M | -13.74M | -9.49M | -13.64M | -11.13M |
| Pretax Income | -25.2M | 63.67M | -31.33M | -12.72M | -40.45M | -21.32M | -29.52M | -61.92M | 61.02M | -56.34M | -41.25M | -49.94M | -61.72M | -55.49M | -55.12M | -66.32M | -56.73M | -65.12M | -69.39M | -43.67M |
| Pretax Margin % | -31.45% | 37.8% | -35.89% | -15.45% | -62.24% | -30.85% | -57.18% | -83.87% | 44.3% | -174.71% | -121.43% | -193.65% | -253.68% | -294.86% | -290.4% | -352.02% | -301.18% | -422.82% | -481.55% | -107.4% |
| Income Tax | 0 | 1.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 2.89% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -25.2M | 61.83M | -31.33M | -12.72M | -40.45M | -21.32M | -29.52M | -61.92M | 61.02M | -56.34M | -41.25M | -49.94M | -61.72M | -55.49M | -55.12M | -66.32M | -56.73M | -65.12M | -69.39M | -43.67M |
| Net Margin % | -31.45% | 36.71% | -35.89% | -15.45% | -62.24% | -30.85% | -57.18% | -83.87% | 44.3% | -174.71% | -121.43% | -193.65% | -253.68% | -294.86% | -290.4% | -352.02% | -301.18% | -422.82% | -481.55% | -107.4% |
| Net Income Growth % | 37.72% | 390.04% | -6.13% | 79.45% | -166.3% | 62.16% | 28.43% | -24.01% | 198.87% | -1.54% | 25.16% | 24.71% | -8.79% | 14.79% | 20.56% | -51.88% | 37.61% | 37.67% | 18.79% | -135.04% |
| Net Income (Continuing) | -25.2M | 61.83M | -31.33M | -12.72M | -40.45M | -21.32M | -29.52M | -61.92M | 61.02M | -56.34M | -41.25M | -49.94M | -61.72M | -55.49M | -55.12M | -66.32M | -56.73M | -65.12M | -69.39M | -43.67M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.10 | 0.22 | -0.16 | -0.02 | -0.21 | -0.11 | -0.15 | -0.33 | 0.34 | -0.50 | -0.37 | -0.46 | -1.14 | -0.93 | -1.01 | -1.27 | -1.16 | -1.77 | -2.62 | -1.67 |
| EPS Growth % | 52.38% | 300% | -6.67% | 92.67% | -161.76% | 78% | 59.46% | 28.26% | 129.82% | 46.24% | 63.37% | 63.78% | 1.72% | 47.46% | 61.45% | 23.95% | 66.86% | 54.5% | 14.66% | -138.66% |
| EPS (Basic) | -0.10 | 0.26 | -0.16 | -0.02 | -0.21 | -0.11 | -0.15 | -0.33 | 0.36 | -0.50 | -0.37 | -0.46 | -1.14 | -0.93 | -1.01 | -1.27 | -1.16 | -1.77 | -2.62 | -1.67 |
| Diluted Shares Outstanding | 251.35M | 284.57M | 198.15M | 196.84M | 196.13M | 195.57M | 194.93M | 188.79M | 189.64M | 112.4M | 111.87M | 109.24M | 78.44M | 73.49M | 67.81M | 63.23M | 60.95M | 36.85M | 26.46M | 26.23M |
| Basic Shares Outstanding | 251.35M | 236.68M | 198.15M | 196.84M | 196.13M | 195.57M | 194.93M | 188.79M | 169.26M | 112.4M | 111.87M | 109.24M | 78.44M | 73.49M | 67.81M | 63.23M | 60.95M | 36.85M | 26.46M | 26.23M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |